Vanguard Group Inc Anebulo Pharmaceuticals, Inc. Call Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ANEB
# of Institutions
16Shares Held
7.31MCall Options Held
0Put Options Held
0-
22 Nw, LP Seattle, WA5.37MShares$12.9 Million15.16% of portfolio
-
Lvw Advisors, LLC642KShares$1.54 Million0.32% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT511KShares$1.23 Million0.09% of portfolio
-
Morgan Stanley New York, NY399KShares$958,1250.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX158KShares$378,8680.06% of portfolio
About Anebulo Pharmaceuticals, Inc.
- Ticker ANEB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,633,200
- Market Cap $61.5M
- Description
- Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...